Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Odfjell awarded for trainee program in Norway

The Norwegian Prime Minister Erna Solberg has announced Odfjell as recipient of the Foundation for Norwegian Maritime Competence’s annual award. In her speech, the Prime Minister highlighted Odfjell’s long-term efforts to recruit and train young maritime talents.The award is established to inspire recruitment and recognize shipowners who offer training programs to young maritime talents. When awarding Odfjell with the prize, Prime Minister Solberg said: - Norway is one of the world’s leading maritime nations, and we are the world’s fourth-largest shipping nation. To maintain and

Notice to participate at the Annual General Meeting of Shareholders of DDM Holding AG

The Swiss Federal Government has declared a “special situation” in Switzerland due to the COVID-19 pandemic. Protecting the health of our shareholders and employees is a priority for us. Therefore, the personal attendance of the shareholders at the annual general shareholders’ meeting (the “AGM”) of DDM Holding AG (First North Growth Market: DDM), (the “Company”) is not possible. This year’s AGM will take place on Tuesday 22 June 2021 at 11:00 am CEST at the offices of Walder Wyss Ltd, Seefeldstr. 123, 8008 Zurich. As a consequence, shareholders can, in line with art. 27 of the Swiss

Handelsbanken cuts the calculation interest rate for mortgage loans to 6 per cent

Handelsbanken is cutting the calculation interest rate used in the assessment of mortgage loan applications to 6 per cent. The reduction is being implemented in response to changes in the overall interest environment.“The calculation interest rate is a key part of our assessment of a customer’s long-term repayment capacity.  Following this reduction, our assessments will more accurately reflect the current interest environment, and will help more people to take their first steps on to the property ladder and buy their dream home. Of course, this change will not compromise the care and

EQT Growth leads investment in Bought By Many, a leading European pet insurance provider

· EQT Growth invests in Bought By Many, a leading digital-first provider of pet insurance across the UK, Sweden and the US, as part of its USD 350 million Series D round  · Bought By Many benefits from secular tailwinds such as increasing “pet humanization” and rising number of pets, while global penetration of pet insurance remains low  · EQT Growth will support Bought By Many in its accelerated expansion into new geographies, while it also continues to invest in product innovation. Following the investment, Carolina Brochado, Partner in EQT Growth’s advisory team, will join

Management changes in Catella AB (publ)

The Board of directors of Catella AB (publ) has decided to appoint current acting Chief Financial Officer (CFO) Mattias Brodin to CFO as of 1 August 2021.On 1 June, Michel Fischier will take on the role as Head of Investor Relations and Group Communications and Johanna Bjärnemyr joins as Head of Group Legal.Mattias Brodin has held the position of acting CFO since 26 March 2021. Before that, he has held positions as Interim Group CFO at Transcendent Group (publ.) and previously similar positions at Estate Group Sverige and Apoteksgruppen. Mattias Brodin has extensive knowledge of Real

Prostatype Genomics strengthens customer offer and logistics with switch to new contract manufacturer Minerva Biolabs

Prostatype® will be offered as a dry powder solutionProstatype Genomics has entered into a multiyear agreement with the German company Minerva Biolabs GmbH (“Minerva”) for manufacturing of the Company´s prognostic biomarker Prostatype® RT-qPCR kit. Minerva was established in 1999 and is a spin off from the well renowned Robert-Koch Institute in Berlin.  Prostatype Genomic’s CEO Fredrik Persson comments: “We are extremely happy to have agreed with Minerva Biolabs for manufacturing of Prostatype® over the years to come, which is an important step in the continued development of Prostatype

Kekkilä-BVB, the European market leader in horticulture expands business to China

As part of its growth strategy Kekkilä-BVB expands its business to the horticultural market in China in full scale. Kekkilä-BVB’s brands, Kekkilä Professional and BVB Substrates are already having a strong foothold in the Chinese market. Sustainability is at the core of Kekkilä-BVB’s business and supporting China’s high ambitions in sustainability developments. Water is a rare and expensive resource in China. Kekkilä-BVB’s substrates that lower water usage and require less fertilisers will bring savings for growers and enable more efficient use of these important resources. Kekkilä-BVB’s new

Vestas to strengthen commercial setup and appoint Javier Rodriguez Diez to succeed Juan Araluce as Chief Sales Officer

News release from Vestas Wind Systems A/SAarhus, 01 June 2021The world needs a historical surge in investments in renewable energy to reach net zero by 2050[1], and as a global leader in sustainable energy solutions, Vestas seeks to play an instrumental part in helping the world eliminate CO\2\ emissions. The acceleration of deployment of renewables is key to these efforts, and Vestas is therefore taking steps to scale and structure our organisation efficiently to support our customers across the globe and meet current and future demand for sustainable energy solutions. As a next

Why so few are treated with artificial hearts – expert explains

As early as the 1970s, artificial heart implants were performed in patients with life-threatening heart failure. Despite this, only about 2,000 people have been treated to date. At the same time, heart failure is increasing and today 64 million are affected worldwide. What is the reason why so few patients are treated with artificial hearts? Realheart's CEO Ina Laura Perkins asked Professor Robert D Dowling, also a member of the company's scientific advisory board.‘’I am often asked this and, ironically, the fact that so few implants with artificial hearts are performed is also part of the

TRANSCOM HOLDING AB (PUBL) PROPOSES OFFERING OF €300.0 MILLION OF SENIOR SECURED FLOATING RATE NOTES AND GIVES CONDITIONAL NOTICE OF REDEMPTION OF OUTSTANDING NOTES

Stockholm, Sweden – June 1, 2021. Transcom Holding AB (publ), a public limited liability company (aktiebolag) organized and existing under the laws of Sweden (the “Issuer”), announced today that it intends to offer €300.0 million in aggregate principal amount of senior secured floating rate notes due 2026 (the “Notes”), subject to market and other conditions. The Issuer will use the proceeds of the Notes (i) to refinance certain existing indebtedness of the Issuer and of its subsidiaries (the “Group”), including its existing senior secured notes, its existing senior unsecured notes, its

Kiilto’s growth is the result of courage, desire and ability to renew

For many, stability means that things remain the same, unchanged. At Kiilto, a multi-sector company that has been in the business for over 100 years, stable success is an enabler of growth, an engine of renewal and a springboard for innovations.Kiilto, founded in Finland and operating today in 11 countries, isn’t planning on staying put in the future either: its vision is looking ahead to 2080, while the goal of carbon neutral Kiilto  will be achieved much closer in the future, by 2028.   “Steady growth means

Kallelse till årsstämma

Aktieägarna i SpectrumOne AB (publ), org. nr 559079-6958 ("Bolaget") kallas härmed till årsstämma onsdagen den 30 juni 2021 klockan 11:00 i Bolagets lokaler på Kungsgatan 60, Stockholm. Rätt att delta på stämmanAktieägare som önskar delta vid stämman ska dels vara införd i den av Euroclear Sweden AB förda aktieboken per den 21 juni 2021 och dels senast den 24 juni 2021 anmäla sitt deltagande till Bolaget antingen per post till SpectrumOne AB, Att: Bolagsstämma, Kungsgatan 60, 111 22 Stockholm. Anmälan kan också göras per e-post till info@SpectrumOne.com (info@bellpal.com)  eller per

Hemispheres onboard with Biomaster antimicrobial protection

When Covid-19 took hold in 2020 one of the first precautions most airlines took was toremove inflight magazines from seat-back pockets. In fact, four of the top five U.S. airlinesremoved their traveller magazines. However a year on, Hemispheres - the award-winninginflight magazine, will soon be back onboard flights thanks to Biomaster technology. Hemispheres is published by Ink Global and produced in New York and Miami. The magazineis circulated monthly and reaches 139 million business and leisure travellers annually.Biomaster antimicrobial technology present within the

Asaleo Care's shareholders accept Essity's offer to acquire remaining shares in the company

Further to the announcement on February 16, 2021, that the hygiene and health company Essity had entered an agreement to acquire the remaining 63.8% of the shares in the Australian hygiene company Asaleo Care, Essity today notes the announcement by Asaleo Care, that the company’s shareholders voted in favor of accepting Essity’s offer.Essity will acquire the remaining 63.8% of the shares in Asaleo Care for AUD 1.40 cash per share. The consideration implies an equity value on a 100% basis of approximately AUD 760m (approximately SEK 4.9bn) and an enterprise value of AUD 855m (approximately

Staffan Ternström new COO Diagnostic Services

Staffan Ternström is appointed new Chief Operating Officer (COO) for Diagnostic Services and member of the Executive Management Team, effective from 28 June 2021. Staffan Ternström has a long professional and international experience and has been President and CEO of Handicare Group, Executive Vice President of Global Commercial Operations and Strategy at Mölnlycke Health Care AB and has a long career at Johnson & Johnson in various positions. For further information, please contact: Hanna Bjellquist, Head of Investor Relations +46 703 033 272hanna.bjellquist@medicover.com

Inhalation Sciences ramps up remote installation and digital training with third major project

(Stockholm, Sweden, June 1, 2021) On 19-20 May ISAB digitally trained the lab team at Aquilon Pharma to remotely install and operate its new PreciseInhale[®] system, the third remote installation and training project carried out in recent months. Aquilon Pharma founder Professor Didier Cataldo: “With this process, we acquired step-by-step in-depth knowledge of the real capacities of this equipment. PreciseInhale[®] is the perfect multifunctional tool, that will become central in our developments of formulations for inhalation.”Throughout Spring 2021, at sites across Europe, ISAB has carried

Martin Johannesson new Head of business area Property Management

Martin Johannesson will assume the position as new business area manager at K-Fastigheter. Martin comes most recently from Akademiska Hus, where he is currently property manager.Martin Johannesson has solid experience of operational property management in roles such as real estate manager and property manager with commercial premises as well as housing in his portfolio. He has a master’s degree in engineering from Lund University’s Faculty of Engineering, LTH. “A lot is going on in the real estate industry and I look forward to contributing to issues that are important today and not

Alelion receives SEK 23,5m by exercising of warrants of series TO2 with an exercise rate of 93%

Alelion Energy Systems AB (“Alelion or the Company”) carried out a rights issue of shares and free-of-charge warrants during October 2020. The exercise period of the warrants of series TO2 was between May 14 – 28 2021, and thus has ended. In total, 70 526 510 warrants of series TO2 were used to subscribe for shares, corresponding to an exercise rate of approximately 93 percent.In total, 70 526 510 warrants, corresponding to approximately 93 percent of the total number, were used to subscribe for 23 508 835 shares at a subscription price of SEK 1,0 per share. Through the exercise of warrants,

Medivir to present at the Redeye Growth Day

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the virtual meeting Redeye Growth Day on June 2, 2021.The presentation is live broadcasted and can be followed at:https://www.redeye.se/events/808637/redeye-growth-day-2021The presentation will be available after the meeting on Medivirs website; www.medivir.com.For additional information, please contactMagnus Christensen, interim CEO and CFOTelephone: +46 8 5468 3100E-mail: magnus.christensen@medivir.com   Medivir in briefMedivir develops innovative drugs with a

Outokumpu reduced net debt with the proceeds of the directed share issue

Outokumpu OyjStock exchange releaseJune 1, 2021 at 9.30 am EESTOutokumpu reduced net debt with the proceeds of the directed share issue Outokumpu has prepaid loans from financial institutions by 210 million euros with the proceeds of the directed share issue, completed on May 10, 2021. Deleveraging and strengthening the balance sheet are key targets of the company strategy launched in November 2020. On March 31, 2021, Outokumpu’s Annual General Meeting authorized the Board of Directors to decide upon a directed share issue. Says CFO Pia Aaltonen-Forsell: “We completed the directed

SynAct Pharma completes recruitment and dosing in part 2 of the clinical Phase II study with AP1189 in Covid-19 infected patients

SynAct Pharma AB ("SynAct") today announced that dosing in part 2 of the exploratory clinical Phase 2 study with AP1189 in Covid-19 patients conducted under the RESOVIR collaboration has been completed. The study is a randomized double-blind placebo-controlled study in 54 Covid-19 patients at clinical sites at Universidade Federal de Minas, Belo Horizonte, Brazil.The aim of the study is to evaluate the safety and efficacy of a two-week dosing regimen with AP1189 vs placebo as add-on therapy in patients with Covid-19 induced pulmonary insufficiency, defined as a need for supplementary oxygen

Ovako’s Sustainability Report for 2020 outlines direction for new ambitious climate targets

The new report highlights Ovako’s leadership in sustainable steel production with a 54 percent reduction in CO\2\ emissions since 2015 and a carbon footprint for its steel products that is 80 percent lower than the global average. It also sets new targets to build on these achievements through to 2040.Ovako has published a Sustainability Report  covering its activities during 2020. It shows that the company made significant sustainability improvements while also adapting to the health, safety

Read original

Decision to develop the Hasselmus gas discovery

Draugen operator OKEA ASA and partners Petoro AS and Neptune Energy Norge AS have made the decision to develop the Hasselmus gas discovery.  Hasselmus will be the first tie-back to the Draugen production platform and will add in excess of 4,000 barrels of oil equivalents per day to the production.The Hasselmus project is expected to recover approximately 1.65 GSm[3] (10.6 million barrels of oil equivalents) as fuel and export gas and will also make possible the restart of export of associated gas including NGL which is currently being injected into the reservoir. The development concept

ABAX switches to HERE as default map provider

June 2021 - Larvik and AmsterdamABAX is happy to announce that they have signed a new default map provider to improve their customer experience. ABAX will be using HERE Technologies' geocoding, map tiles, routing, speed limits and route matching on all their SaaS services.All future customers of ABAX will see all their assets, tools, vehicles and machines in the HERE-map as default, and it is the start of a great partnership for future development in the ABAX solution. By partnering with HERE, we will strengthen this position even further, opening up a range of potential new services

Read original
There are no items matching the current filter
There are no more items matching the current filter
Back to top